RTW INVESTMENTS, LP Diversified Active

Location: New York, NY

CIK: 0001493215 · Show all filings

Period: Q3 2016 (← Previous) (Next →)

Filing Date: Nov 18, 2016

Total Value: $331M (100.0% shares, 0.0% debt)

Holdings (36)

ALNY Alnylam Pharmaceuticals Inc 19.4%
Value $64.28M Shares 948,286 Est. Cost $86.12 Unrealized -18.1%
Avexis Inc 10.3%
Value $34.04M Shares 825,980 Est. Cost $33.15 Unrealized
Agenus Inc 9.0%
Value $29.74M Shares 4,141,644 Est. Cost $7.65 Unrealized
La Jolla Pharmaceutical Co 8.4%
Value $27.84M Shares 1,170,151 Est. Cost $25.02 Unrealized
BCRX BioCryst Pharmaceuticals Inc 5.6%
Value $18.54M Shares 4,204,579 Est. Cost $7.25 Unrealized -44.9%
INCY Incyte Corp 5.4%
Value $18.02M Shares 191,151 Est. Cost $74.63 Unrealized +12.9%
Achillion Pharmaceuticals Inc 5.4%
Value $17.89M Shares 2,208,749 Est. Cost $10.21 Unrealized
Dicerna Pharmaceuticals Inc 3.6%
Value $11.92M Shares 2,026,894 Est. Cost $13.12 Unrealized
BMY Bristol-Myers Squibb Co 3.4%
Value $11.31M Shares 209,701 Est. Cost $48.14 Unrealized -4.1%
GLD SPDR Gold Trust 3.2%
Value $10.43M Shares 83,000 Est. Cost $126.47 Unrealized
Atara Biotherapeutics Inc. 3.0%
Value $9.799M Shares 458,113 Est. Cost $21.39 Unrealized
ARWR Arrowhead Pharmaceuticals Inc 2.5%
Value $8.208M Shares 1,116,777 Est. Cost $6.48 Unrealized 0.0%
HRTX Heron Therapeutics Inc 2.0%
Value $6.664M Shares 386,787 Est. Cost $18.55 Unrealized 0.0%
Viveve Medical Inc 1.8%
Value $6.06M Shares 839,274 Est. Cost $4.19 Unrealized
bluebird bio Inc 1.8%
Value $5.947M Shares 87,734 Est. Cost $43.60 Unrealized
Corium International Inc 1.8%
Value $5.888M Shares 1,045,747 Est. Cost $9.36 Unrealized
Invuity Inc 1.6%
Value $5.39M Shares 392,838 Est. Cost $13.24 Unrealized
Celldex Therapeutics Inc 1.5%
Value $5.022M Shares 1,243,164 Est. Cost $12.18 Unrealized
Medicines Co 1.4%
Value $4.642M Shares 123,000 Est. Cost $37.74 Unrealized
OMER Omeros Corp 1.3%
Value $4.274M Shares 383,012 Est. Cost $14.29 Unrealized -20.1%
TCMD Tactile Systems Technology Inc Cmn 1.3%
Value $4.256M Shares 227,599 Est. Cost $15.35 Unrealized 0.0%
Barclays Bank Plc 1.2%
Value $4.018M Shares 180,500 Est. Cost $22.17 Unrealized
RGNX Regenxbio Inc 1.0%
Value $3.345M Shares 238,740 Est. Cost $24.07 Unrealized -54.2%
Oxford Immunotec Global PLC 0.9%
Value $2.963M Shares 235,900 Est. Cost $12.56 Unrealized
Five Prime Therapeutics Inc 0.7%
Value $2.312M Shares 44,044 Est. Cost $22.81 Unrealized
Global Blood Therapeutics Inc 0.7%
Value $2.206M Shares 95,714 Est. Cost $35.72 Unrealized
MASI Masimo Corp 0.5%
Value $1.541M Shares 25,900 Est. Cost $40.86 Unrealized +38.1%
NOVAVAX INC 0.3%
Value $996K Shares 4,787 Est. Cost Unrealized
Mirati Therapeutics Inc 0.3%
Value $854K Shares 129,129 Est. Cost $33.11 Unrealized
SRTS Sensus Healthcare Inc Cmn 0.2%
Value $773K Shares 125,700 Est. Cost $6.26 Unrealized 0.0%
Biopharmx Corp 0.1%
Value $389K Shares 700,636 Est. Cost $1.87 Unrealized
Audentes Therapeutics Inc 0.1%
Value $356K Shares 20,000 Est. Cost $17.80 Unrealized
NTRA Natera Inc 0.1%
Value $352K Shares 31,693 Est. Cost $16.90 Unrealized -33.3%
MANNKIND CORP 0.1%
Value $272K Shares 4,385 Est. Cost Unrealized
Nivalis Therapeutics Inc 0.1%
Value $244K Shares 30,000 Est. Cost $15.17 Unrealized
Abeona Therapeutics Inc 0.0%
Value $116K Shares 19,391 Est. Cost $5.98 Unrealized